Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Csp (CSPI) Asset Writedowns and Impairment (2016 - 2025)

Historic Asset Writedowns and Impairment for Csp (CSPI) over the last 14 years, with Q4 2025 value amounting to -$27000.0.

  • Csp's Asset Writedowns and Impairment fell 55000.0% to -$27000.0 in Q4 2025 from the same period last year, while for Dec 2025 it was $74000.0, marking a year-over-year decrease of 6243.65%. This contributed to the annual value of $182000.0 for FY2025, which is 4858.76% down from last year.
  • Latest data reveals that Csp reported Asset Writedowns and Impairment of -$27000.0 as of Q4 2025, which was down 55000.0% from $81000.0 recorded in Q3 2025.
  • In the past 5 years, Csp's Asset Writedowns and Impairment ranged from a high of $189000.0 in Q3 2024 and a low of -$50000.0 during Q1 2022
  • In the last 5 years, Csp's Asset Writedowns and Impairment had a median value of $17000.0 in 2022 and averaged $36500.0.
  • Per our database at Business Quant, Csp's Asset Writedowns and Impairment soared by 1560000.0% in 2022 and then tumbled by 55000.0% in 2025.
  • Over the past 5 years, Csp's Asset Writedowns and Impairment (Quarter) stood at $5000.0 in 2021, then surged by 860.0% to $48000.0 in 2022, then crashed by 33.33% to $32000.0 in 2023, then tumbled by 81.25% to $6000.0 in 2024, then crashed by 550.0% to -$27000.0 in 2025.
  • Its last three reported values are -$27000.0 in Q4 2025, $81000.0 for Q3 2025, and $42000.0 during Q2 2025.